You are here

Europe

What to Expect for AstraZeneca in Fiscal 2018

What to Expect for AstraZeneca in Fiscal 2018

Market Realist

Flag link:

Brexit Is Seen Costing Pharma Hundreds of Millions of Pounds

Brexit Is Seen Costing Pharma Hundreds of Millions of Pounds

Bloomberg

pharma industry

Flag link:

How Novartis, Insurers Are Taking Wind Out Of AbbVie's Sales

How Novartis, Insurers Are Taking Wind Out Of AbbVie's Sales

Investors Business Daily

Flag link:

Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar

Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar

CP Wire

Flag link:

EU makes it easier for companies to produce generic medicines for export

EU makes it easier for companies to produce generic medicines for export

Reuters

European Commission

Flag link:

Novartis receives EU approval for biosimilar Zessly

Novartis receives EU approval for biosimilar Zessly

Reuters

Flag link:

ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV

ViiV Receives EU Authorization for Juluca, the First 2-Drug, Once-Daily Pill for HIV

CP Wire

ViiV Healthcare

Flag link:

[video]How Drug Approvals in Europe Are Different Than in the United States

[video]How Drug Approvals in Europe Are Different Than in the United States

Motley Fool

Flag link:

BioLineRx Receives European Patent Covering BL-8040 with Cytarabine for Acute Myeloid Leukemia

BioLineRx Receives European Patent Covering BL-8040 with Cytarabine for Acute Myeloid Leukemia

CP WIre

acute myeloid leukemia

Flag link:

Sarepta’s eteplirsen spurned as European regulators turn thumbs down on controversial Duchenne MD drug

Sarepta’s eteplirsen spurned as European regulators turn thumbs down on controversial Duchenne MD drug

Endpoints

Sarepta Therapeutics

Duchenne Muscular Dystrophy

Flag link:

EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer

EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer

CP Wire

Bristol-Myers Squibb

metastatic non-small cell lung cancer

Flag link:

Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe

Mundipharma and Celltrion Heathcare Launch Herceptin Biosimilar Herzuma in Europe

CP Wire

Flag link:

AbbVie Submits Marketing Application to the European Medicines Agency for Risankizumab in Plaque Psoriasis

AbbVie Submits Marketing Application to the European Medicines Agency for Risankizumab in Plaque Psoriasis

CP Wire

Flag link:

Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

RAPS.org

Flag link:

GSK's two-drug HIV regimen wins European panel approval

GSK's two-drug HIV regimen wins European panel approval

Reuters

Flag link:

EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017

EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017

RAPS.org

Portola Pharmaceuticals

Flag link:

Teva takes issue with EC charges of pay-for-delay deal with Cephalon

Teva takes issue with EC charges of pay-for-delay deal with Cephalon

Seeking Alpha

Teva Pharmaceuticals

Flag link:

GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma

GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma

Businesswire

Flag link:

Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases

Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases

Endpoints

multiple sclerosis

Flag link:

Why Achillion Pharmaceuticals, Inc. Stock Spiked Monday

Why Achillion Pharmaceuticals, Inc. Stock Spiked Monday

Motley Fool

Flag link:

Pages